Canada Life’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,800
| Closed | -$485K | – | 2578 |
|
|
2021
Q3 | $485K | Sell |
2,800
-381
| -12% | -$49.8K | ﹤0.01% | 1736 |
|
|
2021
Q2 | $399K | Sell |
3,181
-51
| -2% | -$6.43K | ﹤0.01% | 1787 |
|
|
2021
Q1 | $435K | Sell |
3,232
-298
| -8% | -$38.5K | ﹤0.01% | 1777 |
|
|
2020
Q4 | $449K | Buy |
3,530
+416
| +13% | +$48.8K | ﹤0.01% | 1779 |
|
|
2020
Q3 | $350K | Hold |
3,114
| – | – | ﹤0.01% | 1774 |
|
|
2020
Q2 | $295K | Hold |
3,114
| – | – | ﹤0.01% | 1810 |
|
|
2020
Q1 | $282K | Hold |
3,114
| – | – | ﹤0.01% | 1745 |
|
|
2019
Q4 | $164K | Buy |
+3,114
| New | +$142K | ﹤0.01% | 1968 |
|
|
2019
Q3 | – | Sell |
-5,890
| Closed | -$242K | – | 2564 |
|
|
2019
Q2 | $242K | Sell |
5,890
-1,033
| -15% | -$42.8K | ﹤0.01% | 1980 |
|
|
2019
Q1 | $321K | Buy |
6,923
+1,843
| +36% | +$80.9K | ﹤0.01% | 1763 |
|
|
2018
Q4 | $213K | Hold |
5,080
| – | – | ﹤0.01% | 1921 |
|
|
2018
Q3 | $291K | Hold |
5,080
| – | – | ﹤0.01% | 1885 |
|
|
2018
Q2 | $246K | Hold |
5,080
| – | – | ﹤0.01% | 1916 |
|
|
2018
Q1 | $199K | Hold |
5,080
| – | – | ﹤0.01% | 1964 |
|
|
2017
Q4 | $215K | Buy |
5,080
+2,455
| +94% | +$92.1K | ﹤0.01% | 1950 |
|
|
2017
Q3 | $94K | Hold |
2,625
| – | – | ﹤0.01% | 2171 |
|
|
2017
Q2 | $80K | Hold |
2,625
| – | – | ﹤0.01% | 2179 |
|
|
2017
Q1 | $69K | Hold |
2,625
| – | – | ﹤0.01% | 2219 |
|
|
2016
Q4 | $67K | Hold |
2,625
| – | – | ﹤0.01% | 2244 |
|
|
2016
Q3 | $95K | Hold |
2,625
| – | – | ﹤0.01% | 2152 |
|
|
2016
Q2 | $89K | Sell |
2,625
-2,772
| -51% | -$90.1K | ﹤0.01% | 2146 |
|
|
2016
Q1 | $142K | Buy |
5,397
+3,767
| +231% | +$110K | ﹤0.01% | 1539 |
|
|
2015
Q4 | $79K | Hold |
1,630
| – | – | ﹤0.01% | 1919 |
|
|
2015
Q3 | $41K | Hold |
1,630
| – | – | ﹤0.01% | 2162 |
|
|
2015
Q2 | $51K | Hold |
1,630
| – | – | ﹤0.01% | 2213 |
|
|
2015
Q1 | $62K | Buy |
+1,630
| New | +$64.8K | ﹤0.01% | 2040 |
|
Canada Life's XLRN Position: Q4 2021 in Review
Canada Life sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,800 shares — an estimated $485K sold.
Canada Life first reported a position in XLRN in Q1 2015 and held it in 26 quarters. The position peaked at $485K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Canada Life reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Canada Life sold 2,800 Acceleron Pharma shares in Q4 2021, an estimated $485K.
- Canada Life first reported a position in Acceleron Pharma in Q1 2015 and held it in 26 quarters.
- Canada Life's Acceleron Pharma position peaked at $485K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.